missing translation for 'onlineSavingsMsg'
Learn More
Learn More
Invitrogen™ LentiArray™ CRISPR Positive Control Lentivirus, human HPRT 
Optimizing delivery conditions is a critical step in any experiment utilizing the CRISPR/Cas9 system.
$744.00 - $3110.00
Specifications
| Control Type | Positive Control |
|---|---|
| Delivery Type | Lentiviral |
| Promoter | U6 |
| Transfection Technique | Lentiviral transduction |
| Species | Human |
Alert:
For Research Use Only. Not for use in diagnostic procedures.
Description
Optimizing delivery conditions is a critical step in any experiment utilizing the CRISPR/Cas9 system. The Invitrogen™ LentiArray™ CRISPR Positive Control Lentivirus gRNA against HPRT is a highly efficient gRNA validated in multiple human cell lines that has achieved editing efficiencies of greater than 80%. It can be used to rapidly determine ideal delivery conditions in order to achieve maximum editing efficiency in your cell model of choice.
The Invitrogen™ LentiArray™ CRISPR Positive Control Lentivirus gRNA against HPRT is a highly efficient gRNA validated in multiple human cell lines that has achieved editing efficiencies of greater than 80%. It can be used to rapidly determine ideal delivery conditions in order to achieve maximum editing efficiency in your cell model of choice.
Specifications
| Positive Control | |
| U6 | |
| Human | |
| LentiArray |
| Lentiviral | |
| Lentiviral transduction | |
| CRISPR gene knockout | |
| Dry Ice |
For Research Use Only. Not for use in diagnostic procedures.